Patricia Van Arnum

Lonza (Basel, Switzerland), the large contract manufacturer of small-molecule and biologic-based active pharmaceutical ingredients (APIs), announced last week a series of cost-cutting measures for the next 12 to 18 months.

Functionalized supramolecular catalysts and an enantioselective route to unnatural amino acids are some recent developments.

The House Energy and Commerce Committee has approved H.R. 2868, the "Chemical Facility Anti-Terrorism Act of 2009", a measure to modify and codify existing requirements of the Chemical Facility Anti-Terrorism Standards (CFATS) programme.

The House Energy and Commerce Committee approved H.R. 2868, the "Chemical Facility Anti-Terrorism Act of 2009," a measure to modify and codify existing requirements of the Chemical Facility Anti-Terrorism Standards (CFATS) program.

Following the completion of its $68-billion acquisition of Wyeth, Pfizer has begun operations at the new combined company.

Following the completion of its $68-billion acquisition of Wyeth (Madison, NJ), Pfizer (New York) began joint operations of the combined company last week.

GlaxoSmithKline (GSK), Novartis, sanofi aventis and Baxter International have provided updates regarding the development, manufacture and shipment of pandemic (H1NI) vaccines.

A recent analysis by the life-science practice of Capgemini provides insight in how current economic conditions are reshaping the model for supply-chain practices, outsourcing, and other areas of the value chain.

The FDA has issued an alert to healthcare professionals of a change in heparin manufacturing that is expected to decrease the drug?s potency.

Thomas LaVake, manager, worldwide environment, health & safety at Johnson & Johnson, provides a perspective on sustainability practices for the pharmaceutical industry.

The US Food and Drug Administration issued an alert to healthcare professionals of a change in heparin manufacturing that is expected to decrease the drug's potency.

The 2009 Nobel Prize in Physiology or Medicine was awarded to three US researchers for the discovery of how chromosomes are protected from degradation by telomeres and the enzyme telomerase during cell division.

GlaxoSmithKline (London), Novartis (Basel, Switzerland), sanofi Aventis (Paris), and Baxter International (Deerfield, IL) recently provided updates as to the development, manufacture, or shipment of pandemic (H1NI) vaccines.

New nanotechnology-based delivery systems offer promise in drug delivery, particularly for anticancer therapeutics.

Abbott Laboratories (IL, USA) has agreed to acquire the pharmaceutical business of the Solvay Group (Belgium) for 4.5 billion Euros in cash.

The biopharmaceutical company Seattle Genetics (Bothell, WA) introduced a sugar-engineered antibody (SEA) technology that is designed to increase the potency of monoclonal antibodies through enhanced effector function.

Abbott Laboratories (Abbott Park, IL) agreed to acquire the pharmaceutical business of the Solvay Group (Brussels, Belgium) for EUR 4.5 billion ($6.6 billion) in cash, according to an Abbott press release.

The Senate Finance Committee through its chairman, Max Baucus (D-MT), introduced on Sept. 16, 2009, a bill, "America's Healthy Future Act of 2009," representing the latest Congressional proposal for healthcare reform.

In move designed to increase its position in North America, Dainippon Sumitomo Pharma (DSP, Japan) has agreed to acquire the specialty pharmaceutical company Sepracor (MA, USA) for $2.6 billion.

In move designed to increase its position in North America, Dainippon Sumitomo Pharma (DSP, Osaka, Japan) has agreed to acquire the specialty pharmaceutical company Sepracor (Marlborough, MA) for $2.6 billion.

Merck & Co. has outlined a new organizational structure and named top management and senior leaders for the company, effective upon the completion of its merger with Schering-Plough.

Merck & Co. (Whitehouse Station, NJ) outlined a new organizational structure and named top management and senior leaders for the company, effective upon the completion of its merger with Schering-Plough (Kenilworth, NJ).

Select contract manufacturing organizations roll out expansions for production of active pharmaceutical ingredients and intermediates.

A recent review highlights contributions in process research and development and manufacturing using the principles of green chemistry.

Thomas LaVake, manager, worldwide environment, health &safety at Johnson & Johnson, provides a perspective of sustainability practices for the pharmaceutical industry.

Scientists from DSM and Kaneka discuss various techniques in this roundtable moderated by Patricia Van Arnum.

L. Lee Karras, CEO of AAIPharma Services, outlines the company’s growth strategy in contract pharmaceutical development and manufacturing.

Researchers at the J. Craig Venter Institute (JCVI), a US-based genomic research organization, reported that they successfully transformed one bacterium into a different strain by transferring the entire bacterial genome of the first strain into a second, related strain of bacteria.

Researchers at the J. Craig Venter Institute (JCVI), a genomic research organization, reported that they successfully transformed one bacterium into a different strain by transferring the entire bacterial genome of the first strain into a second, related strain of bacteria.

An initiative to develop consensus-based industry standards to identify and define green chemicals and process technologies is underway.